Candel Therapeutics (CADL) 2025 Conference September 04, 2025 08:00 AM ET Speaker0Everyone. Welcome to the second day of Cantor's Global Healthcare Conference. I am delighted to be joined today by Paul Peter Tak, the CEO of Candel Therapeutics. Welcome. So Paul Peter, kick us off by a quick overview of Candel.Speaker1Yes. Well, thanks for having us. It's great to be here. Hi all. Candel Therapeutics develops viral immunotherapies for very difficult to treat solid tumors.And we've shown consistently positive ...